Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8888)
All Articles published online
|
Feb 28, 2012 (publication date) through Jun 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Braunersreuther V, Viviani GL, Mach F, Montecucco F. Role of cytokines and chemokines in non-alcoholic fatty liver disease. World J Gastroenterol 2012; 18(8): 727-735 [PMID: 22371632 DOI: 10.3748/wjg.v18.i8.727] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i8/727.htm |
| Number | Citing Articles |
| 1 |
梦君 廖. Curcumin and Nonalcoholic Fatty Liver Disease. Traditional Chinese Medicine 2019; 8(01): 61 doi: 10.12677/TCM.2019.81013
|
| 2 |
Calvin C. Chan, Michelle S.M.A. Damen, Pablo C. Alarcon, Joan Sanchez-Gurmaches, Senad Divanovic. Inflammation and Immunity: From an Adipocyte's Perspective. Journal of Interferon & Cytokine Research 2019; 39(8): 459 doi: 10.1089/jir.2019.0014
|
| 3 |
K. Dvorshchenko. Changes of energy balance of rat liver and pancreas upon gastric hypoacidity and search of approaches for its recovery. Bulletin of Taras Shevchenko National University of Kyiv. Series: Biology 2014; 68(3): 54 doi: 10.17721/1728_2748.2014.68.54-57
|
| 4 |
Yara Alenazi, Kamayani Singh, Graham Davies, James R. O. Eaton, Philip Elders, Akane Kawamura, Shoumo Bhattacharya. Genetically engineered two-warhead evasins provide a method to achieve precision targeting of disease-relevant chemokine subsets. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-24568-9
|
| 5 |
Stephanie Breher-Esch, Nishika Sahini, Anna Trincone, Christin Wallstab, Jürgen Borlak. Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease. BMC Medical Genomics 2018; 11(1) doi: 10.1186/s12920-018-0438-7
|
| 6 |
Thing-Fong Tzeng, Shorong-Shii Liou, Chia Ju Chang, I-Min Liu. Zerumbone, a Natural Cyclic Sesquiterpene ofZingiber zerumbetSmith, Attenuates Nonalcoholic Fatty Liver Disease in Hamsters Fed on High-Fat Diet. Evidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/303061
|
| 7 |
Yancheng Song, Jan Zhang, Hexiang Wang, Dong Guo, Chentong Yuan, Bo Liu, Hao Zhong, Dongmei Li, Yu Li. A novel immune-related genes signature after bariatric surgery is histologically associated with non-alcoholic fatty liver disease. Adipocyte 2021; 10(1): 424 doi: 10.1080/21623945.2021.1970341
|
| 8 |
Lindsei K. Sarna, Yaw L. Siow, Karmin O. The CBS/CSE system: a potential therapeutic target in NAFLD?. Canadian Journal of Physiology and Pharmacology 2015; 93(1): 1 doi: 10.1139/cjpp-2014-0394
|
| 9 |
Antonella Mosca, Annalisa Crudele, Antonella Smeriglio, Maria Rita Braghini, Nadia Panera, Donatella Comparcola, Arianna Alterio, Maria Rita Sartorelli, Giulia Tozzi, Massimiliano Raponi, Domenico Trombetta, Anna Alisi. Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD. Digestive and Liver Disease 2021; 53(9): 1154 doi: 10.1016/j.dld.2020.09.021
|
| 10 |
|
| 11 |
José F. Català-Senent, Marta R. Hidalgo, Marina Berenguer, Gopanandan Parthasarathy, Harmeet Malhi, Pablo Malmierca-Merlo, María de la Iglesia-Vayá, Francisco García-García. Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studies. Biology of Sex Differences 2021; 12(1) doi: 10.1186/s13293-021-00368-1
|
| 12 |
María Eugenia Inzaugarat, Elena De Matteo, Placida Baz, Diego Lucero, Cecilia Claudia García, Esteban Gonzalez Ballerga, Jorge Daruich, Juan Antonio Sorda, Miriam Ruth Wald, Alejandra Claudia Cherñavsky, Vida A. Dennis. New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans. PLOS ONE 2017; 12(3): e0172900 doi: 10.1371/journal.pone.0172900
|
| 13 |
Yanyan Wang, Xiqiao Zhou, Derrick Zhao, Xuan Wang, Emily C. Gurley, Runping Liu, Xiaojiaoyang Li, Phillip B. Hylemon, Weidong Chen, Huiping Zhou, Gianfranco D. Alpini. Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytes. PLOS ONE 2020; 15(5): e0232630 doi: 10.1371/journal.pone.0232630
|
| 14 |
Florian Padberg, Henrik Hering, Andreas Luch, Sebastian Zellmer. Indirect co-cultivation of HepG2 with differentiated THP-1 cells induces AHR signalling and release of pro-inflammatory cytokines. Toxicology in Vitro 2020; 68: 104957 doi: 10.1016/j.tiv.2020.104957
|
| 15 |
Jingjing Cai, Xiao‐Jing Zhang, Hongliang Li. The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis. Hepatology 2019; 70(3): 1026 doi: 10.1002/hep.30506
|
| 16 |
Hyeonji Kim, Kippeum Lee, Ju-Yeon Kim, Jae-Jung Shim, Junghyun Lim, Joo-Yun Kim, Jung-Lyoul Lee. Lactobacillus helveticus Isolated from Raw Milk Improves Liver Function, Hepatic Steatosis, and Lipid Metabolism in Non-Alcoholic Fatty Liver Disease Mouse Model. Microorganisms 2023; 11(10): 2466 doi: 10.3390/microorganisms11102466
|
| 17 |
Claudia Isabel García-Berumen, Manuel Alejandro Vargas-Vargas, Omar Ortiz-Avila, Rosa María Piña–Zentella, Minerva Ramos-Gómez, María del Consuelo Figueroa–García, Ricardo Mejía-Zepeda, Alain Raimundo Rodríguez–Orozco, Alfredo Saavedra–Molina, Christian Cortés-Rojo. Avocado oil alleviates non-alcoholic fatty liver disease by improving mitochondrial function, oxidative stress and inflammation in rats fed a high fat–High fructose diet. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1089130
|
| 18 |
Sylwia Ziolkowska, Agata Binienda, Maciej Jabłkowski, Janusz Szemraj, Piotr Czarny. The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2021; 22(20): 11128 doi: 10.3390/ijms222011128
|
| 19 |
Samah Alharbi. Exogenous administration of unacylated ghrelin attenuates hepatic steatosis in high-fat diet-fed rats by modulating glucose homeostasis, lipogenesis, oxidative stress, and endoplasmic reticulum stress. Biomedicine & Pharmacotherapy 2022; 151: 113095 doi: 10.1016/j.biopha.2022.113095
|
| 20 |
Saika Manzoor, Mohd Ashraf Ganie, Shajrul Amin, Zaffar A Shah, Imtiyaz A Bhat, S. Douhath Yousuf, Humira Jeelani, Iram A Kawa, Qudsia Fatima, Fouzia Rashid. Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with Polycystic Ovarian Syndrome: An observational study. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-46644-4
|
| 21 |
Roberta Budriesi, Fabio Vivarelli, Donatella Canistro, Rita Aldini, Clara Babot Marquillas, Ivan Corazza, Romana Fato, Silvia Cirillo, Christian Bergamini, Antonia D’Errico, Cristiano Bolchi, Monica Cevenini, Alessio Degiovanni, Maria Frosini, Luca Camarda, Alberto Chiarini, Matteo Micucci, Paula B. Andrade. Liver and intestinal protective effects of Castanea sativa Mill. bark extract in high-fat diet rats. PLOS ONE 2018; 13(8): e0201540 doi: 10.1371/journal.pone.0201540
|
| 22 |
Jingxuan Zhou, Nanhai Zhang, Adil Aldhahrani, Mohamed Mohamed Soliman, Liebing Zhang, Feng Zhou. Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.956688
|
| 23 |
Dongwei Jia, Fangfang Duan, Peike Peng, Linlin Sun, Xiaojuan Liu, Lan Wang, Weicheng Wu, Yuanyuan Ruan, Jianxin Gu, Anna Alisi. Up-Regulation of RACK1 by TGF-β1 Promotes Hepatic Fibrosis in Mice. PLoS ONE 2013; 8(3): e60115 doi: 10.1371/journal.pone.0060115
|
| 24 |
Yoon-Seok Roh, Ekihiro Seki. Obesity, Fatty Liver and Liver Cancer. Advances in Experimental Medicine and Biology 2018; 1061: 45 doi: 10.1007/978-981-10-8684-7_4
|
| 25 |
Brett M. McGettigan, Rachel H. McMahan, Yuhuan Luo, Xiaoxin X. Wang, David J. Orlicky, Cara Porsche, Moshe Levi, Hugo R. Rosen. Sevelamer Improves Steatohepatitis, Inhibits Liver and Intestinal Farnesoid X Receptor (FXR), and Reverses Innate Immune Dysregulation in a Mouse Model of Non-alcoholic Fatty Liver Disease. Journal of Biological Chemistry 2016; 291(44): 23058 doi: 10.1074/jbc.M116.731042
|
| 26 |
Yanbo Fan, Haocheng Lu, Yanhong Guo, Tianqing Zhu, Minerva T. Garcia-Barrio, Zhisheng Jiang, Cristen J. Willer, Jifeng Zhang, Y. Eugene Chen. Hepatic Transmembrane 6 Superfamily Member 2 Regulates Cholesterol Metabolism in Mice. Gastroenterology 2016; 150(5): 1208 doi: 10.1053/j.gastro.2016.01.005
|
| 27 |
Xiangjin Xu, Wenqing Wang, Lu Lin, Pin Chen. Liraglutide in combination with human umbilical cord mesenchymal stem cell could improve liver lesions by modulating TLR4/NF-kB inflammatory pathway and oxidative stress in T2DM/NAFLD rats. Tissue and Cell 2020; 66: 101382 doi: 10.1016/j.tice.2020.101382
|
| 28 |
Nalini Sodum, Gautam Kumar, Sree Lalitha Bojja, Nitesh Kumar, C. Mallikarjuna Rao. Epigenetics in NAFLD/NASH: Targets and therapy. Pharmacological Research 2021; 167: 105484 doi: 10.1016/j.phrs.2021.105484
|
| 29 |
Min Cheol Kim, Kyeong Ok Kim, Min Kyu Kang. Prevalence and associated risk of advanced colorectal neoplasia in adults with sarcopenia. The Korean Journal of Internal Medicine 2022; 37(2): 294 doi: 10.3904/kjim.2020.569
|
| 30 |
Veeral Ajmera, Emily R. Perito, Nathan M. Bass, Norah A. Terrault, Katherine P. Yates, Ryan Gill, Rohit Loomba, Anna Mae Diehl, Bradley E. Aouizerat. Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease. Hepatology 2017; 65(1): 65 doi: 10.1002/hep.28776
|
| 31 |
Qing Shi, Rong Shen, Chao-Fu Wang, Xing Fan, Ying Qian, Bin-Shen Ou-Yang, Yan Zhao, Christophe Leboeuf, Anne Janin, Shu Cheng, Li Wang, Wei-Li Zhao. Pretreatment Liver Injury Predicts Poor Prognosis of DLBCL Patients. Mediators of Inflammation 2017; 2017: 1 doi: 10.1155/2017/7960907
|
| 32 |
Md. Abdul Kader, Md. Masuder Rahman, Shahin Mahmud, Md. Sharif Khan, Shamsunnahar Mukta, Fatama Tous Zohora. A comparative study on the Antihyperlipidemic and antibacterial potency of the shoot and flower extracts of Melastoma malabathricum Linn's. Clinical Phytoscience 2023; 9(1) doi: 10.1186/s40816-023-00355-6
|
| 33 |
Un Jung, Yun-Young Cho, Myung-Sook Choi. Apigenin Ameliorates Dyslipidemia, Hepatic Steatosis and Insulin Resistance by Modulating Metabolic and Transcriptional Profiles in the Liver of High-Fat Diet-Induced Obese Mice. Nutrients 2016; 8(5): 305 doi: 10.3390/nu8050305
|
| 34 |
Hyo-Joon Yang, Yoosoo Chang, Soo-Kyung Park, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Seungho Ryu, Chong Il Sohn. Nonalcoholic Fatty Liver Disease Is Associated with Increased Risk of Reflux Esophagitis. Digestive Diseases and Sciences 2017; 62(12): 3605 doi: 10.1007/s10620-017-4805-6
|
| 35 |
Simon Ströbel, Radina Kostadinova, Katia Fiaschetti-Egli, Jana Rupp, Manuela Bieri, Agnieszka Pawlowska, Donna Busler, Thomas Hofstetter, Katarzyna Sanchez, Sue Grepper, Eva Thoma. A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-01951-7
|
| 36 |
Timothy D. Rohrbach, Amon Asgharpour, Melissa A. Maczis, David Montefusco, L. Ashley Cowart, Pierre Bedossa, Arun J. Sanyal, Sarah Spiegel. FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice. Journal of Lipid Research 2019; 60(7): 1311 doi: 10.1194/jlr.M093799
|
| 37 |
L. E. Tabikhanova, L. P. Osipova, T. V. Churkina, S. S. Kovalev, M. L. Filipenko, E. N. Voronina. Increased Frequencies of the ‒174G and ‒572C IL6 Alleles in Populations of Indigenous Peoples of Siberia Compared to Russians. Molecular Biology 2023; 57(2): 329 doi: 10.1134/S002689332302019X
|
| 38 |
Joost Boeckmans, Karolien Buyl, Alessandra Natale, Valerie Vandenbempt, Steven Branson, Veerle De Boe, Vera Rogiers, Joery De Kock, Robim M. Rodrigues, Tamara Vanhaecke. Elafibranor restricts lipogenic and inflammatory responses in a human skin stem cell-derived model of NASH. Pharmacological Research 2019; 144: 377 doi: 10.1016/j.phrs.2019.04.016
|
| 39 |
Lili Chen, Qianfei Zhang, Chang Yu, Fang Wang, Xiaoni Kong. Functional roles of CCL5/RANTES in liver disease. Liver Research 2020; 4(1): 28 doi: 10.1016/j.livres.2020.01.002
|
| 40 |
Shuhei Yoshida, Masashi Fujita, Teruhide Ishigame, Yasuyuki Kobayashi, Yuya Sumichika, Kenji Saito, Haruki Matsumoto, Jumpei Temmoku, Yuya Fujita, Naoki Matsuoka, Tomoyuki Asano, Shuzo Sato, Hiroshi Watanabe, Hiroshi Yoshida, Shigeru Marubashi, Yuko Hashimoto, Hiromasa Ohira, Kiyoshi Migita. Case report: Unusual development of hepatocellular carcinoma during immunosuppressive treatments against rheumatoid arthritis overlapping Sjögren’s syndrome; cirrhotic steatohepatitis with liver inflammation and fibrosis lurks in autoimmune disorders. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1089492
|
| 41 |
Michelle S. M. A. Damen, Traci E. Stankiewicz, Se-Hyung Park, Robert N. Helsley, Calvin C. Chan, Maria E. Moreno-Fernandez, Jessica R. Doll, Sara Szabo, De’Broski R. Herbert, Samir Softic, Senad Divanovic. Non-hematopoietic IL-4Rα expression contributes to fructose-driven obesity and metabolic sequelae. International Journal of Obesity 2021; 45(11): 2377 doi: 10.1038/s41366-021-00902-6
|
| 42 |
Giuseppina Palladini, Laura G. Di Pasqua, Clarissa Berardo, Veronica Siciliano, Plinio Richelmi, Barbara Mannucci, Anna Cleta Croce, Vittoria Rizzo, Stefano Perlini, Mariapia Vairetti, Andrea Ferrigno. Fatty Acid Desaturase Involvement in Non-Alcoholic Fatty Liver Disease Rat Models: Oxidative Stress Versus Metalloproteinases. Nutrients 2019; 11(4): 799 doi: 10.3390/nu11040799
|
| 43 |
Luis Fontana, Julio Plaza-Díaz, Paula Robles-Bolívar, Héctor Valente-Godínez, María José Sáez-Lara, Francisco Abadía-Molina, Carolina Gómez-Llorente, Ángel Gil, Ana I. Álvarez-Mercado. Bifidobacterium breve CNCM I-4035, Lactobacillus paracasei CNCM I-4034 and Lactobacillus rhamnosus CNCM I-4036 Modulate Macrophage Gene Expression and Ameliorate Damage Markers in the Liver of Zucker-Leprfa/fa Rats. Nutrients 2021; 13(1): 202 doi: 10.3390/nu13010202
|
| 44 |
M Masudur Rahman, Md Golam Kibria, Hasina Begum, Mazhar Haque, Nigar Sultana, Mahfuza Akhter, A H M Rowshon, Faruqe Ahmed, Mahmud Hasan. Prevalence, risk factors and metabolic profile of the non-obese and obese non-alcoholic fatty liver disease in a rural community of South Asia. BMJ Open Gastroenterology 2020; 7(1): e000535 doi: 10.1136/bmjgast-2020-000535
|
| 45 |
Sabira Mohammed, Evan H. Nicklas, Nidheesh Thadathil, Ramasamy Selvarani, Gordon H. Royce, Michael Kinter, Arlan Richardson, Sathyaseelan S. Deepa. Role of necroptosis in chronic hepatic inflammation and fibrosis in a mouse model of increased oxidative stress. Free Radical Biology and Medicine 2021; 164: 315 doi: 10.1016/j.freeradbiomed.2020.12.449
|
| 46 |
Anle Xu, Fei Han, Yuan Zhang, Tao Zhou, Tianxiang Gao. Comparative Transcriptomic Analyses Revealed the Effects of Poly (I:C) on the Liver and Spleen of Argyrosomus japonicus. International Journal of Molecular Sciences 2022; 23(17): 9801 doi: 10.3390/ijms23179801
|
| 47 |
Jarren R. Oates, Melanie C. McKell, Maria E. Moreno-Fernandez, Michelle S. M. A. Damen, George S. Deepe, Joseph E. Qualls, Senad Divanovic. Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02893
|
| 48 |
Xiao-Han Tang, Marta Melis, Changyuan Lu, Andrew Rappa, Tuo Zhang, Jose Jessurun, Steven S. Gross, Lorraine J. Gudas. A retinoic acid receptor β2 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver disease. Journal of Biological Chemistry 2021; 297(6): 101331 doi: 10.1016/j.jbc.2021.101331
|
| 49 |
L. Perez-Martinez, P. Perez-Matute, J. Aguilera-Lizarraga, S. Rubio-Mediavilla, J. Narro, E. Recio, L. Ochoa-Callejero, J.-A. Oteo, J.-R. Blanco. Maraviroc, a CCR5 antagonist, ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD). Journal of Antimicrobial Chemotherapy 2014; 69(7): 1903 doi: 10.1093/jac/dku071
|
| 50 |
Marina Chaves de Oliveira, Zélia Menezes-Garcia, Raquel Duque do Nascimento Arifa, Talles Prosperi de Paula, João Marcus Oliveira Andrade, Sérgio Henrique Sousa Santos, Gustavo Batista de Menezes, Danielle da Glória de Souza, Mauro Martins Teixeira, Adaliene Versiani Matos Ferreira. Platelet-activating factor modulates fat storage in the liver induced by a high-refined carbohydrate-containing diet. The Journal of Nutritional Biochemistry 2015; 26(9): 978 doi: 10.1016/j.jnutbio.2015.04.004
|
| 51 |
Natalia Zhelezniakova, Anastasiia Rozhdestvenska. IL-1β and IL-10: diagnostic and prognostic potential of cytokines in the assessment of progression of non-alcoholic fatty liver disease in patients with hypertension. EUREKA: Health Sciences 2021; (5): 17 doi: 10.21303/2504-5679.2021.001854
|
| 52 |
Samukelisiwe C. Shabalala, Phiwayinkosi V. Dludla, Lawrence Mabasa, Abidemi P. Kappo, Albertus K. Basson, Carmen Pheiffer, Rabia Johnson. The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling. Biomedicine & Pharmacotherapy 2020; 131: 110785 doi: 10.1016/j.biopha.2020.110785
|
| 53 |
Lorna Ewart, Eva-Maria Dehne, Kristin Fabre, Susan Gibbs, James Hickman, Ellinor Hornberg, Magnus Ingelman-Sundberg, Kyung-Jin Jang, David R. Jones, Volker M. Lauschke, Uwe Marx, Jerome T. Mettetal, Amy Pointon, Dominic Williams, Wolfram-Hubertus Zimmermann, Peter Newham. Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery. Annual Review of Pharmacology and Toxicology 2018; 58(1): 65 doi: 10.1146/annurev-pharmtox-010617-052722
|
| 54 |
Tao Zeng, Cui-Li Zhang, Xiu-Lan Zhao, Ke-Qin Xie. Pentoxifylline for the treatment of nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2014; 26(6): 646 doi: 10.1097/MEG.0000000000000068
|
| 55 |
L. F. Torres, B. Cogliati, R. Otton. Green Tea Prevents NAFLD by Modulation of miR-34a and miR-194 Expression in a High-Fat Diet Mouse Model. Oxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/4168380
|
| 56 |
Hammad Ahmed, Muhammad Ihtisham Umar, Salman Imran, Faraza Javaid, Shahzada Khurram Syed, Romana Riaz, Waseem Hassan. TGF-β1 signaling can worsen NAFLD with liver fibrosis backdrop. Experimental and Molecular Pathology 2022; 124: 104733 doi: 10.1016/j.yexmp.2021.104733
|
| 57 |
Doyoung Kwon, Sou Hyun Kim, Seung Won Son, Jinuk Seo, Tae Bin Jeong, Kyung-Mi Kim, Jae-Chul Jung, Mi Sook Jung, Yun-Hee Lee, Young-Suk Jung. Germinated Soybean Embryo Extract Ameliorates Fatty Liver Injury in High-Fat Diet-Fed Obese Mice. Pharmaceuticals 2020; 13(11): 380 doi: 10.3390/ph13110380
|
| 58 |
Yanqin Du, Tanvi Khera, Zhaoli Liu, Magdalena Tudrujek-Zdunek, Anna Dworzanska, Markus Cornberg, Cheng-Jian Xu, Krzysztof Tomasiewicz, Heiner Wedemeyer. Controlled Attenuation Parameter Is Associated with a Distinct Systemic Inflammatory Milieu after Clearance of HCV Infection. Biomedicines 2023; 11(6): 1529 doi: 10.3390/biomedicines11061529
|
| 59 |
Hilmar K Lückhoff, Frederik C Kruger, Maritha J Kotze. Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries. World Journal of Hepatology 2015; 7(9): 1192-1208 doi: 10.4254/wjh.v7.i9.1192
|
| 60 |
Sara Youssry, Maher A. Kamel. Effect of folate supplementation on immunological and autophagy markers in experimental nonalcoholic fatty liver disease. European Cytokine Network 2019; 30(4): 135 doi: 10.1684/ecn.2019.0437
|
| 61 |
Feng Xiao, Shar L. Waldrop, Steve F. Bronk, Gregory J. Gores, Laurie S. Davis, Gordan Kilic. Lipoapoptosis induced by saturated free fatty acids stimulates monocyte migration: a novel role for Pannexin1 in liver cells. Purinergic Signalling 2015; 11(3): 347 doi: 10.1007/s11302-015-9456-5
|
| 62 |
Victoria L. Gadd, Preya J. Patel, Sara Jose, Leigh Horsfall, Elizabeth E. Powell, Katharine M. Irvine, Alexandre Boissonnas. Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation. PLOS ONE 2016; 11(6): e0157771 doi: 10.1371/journal.pone.0157771
|
| 63 |
Simon Haefliger, Dina Milowich, Amedeo Sciarra, Mounir Trimeche, Justine Bouilly, Julie Kaiser, Stephanie Volpi, Jean-Philippe Brouland, Christine Sempoux, Laurence de Leval. Primary hepatic marginal B cell lymphoma of mucosa-associated lymphoid tissue (MALT) and non-alcoholic steatohepatitis (NASH): more than a coincidence?. Annals of Hematology 2019; 98(6): 1513 doi: 10.1007/s00277-018-3565-5
|
| 64 |
Shaniko Shini, Agim Shini, Wayne L. Bryden. Unravelling fatty liver haemorrhagic syndrome: 2. Inflammation and pathophysiology. Avian Pathology 2020; 49(2): 131 doi: 10.1080/03079457.2019.1682119
|
| 65 |
Naveen Kaushal, Megha Gupta, Era Kulshreshtha. Hempseed (Cannabis sativa) lipid fractions alleviate high-fat diet-induced fatty liver disease through regulation of inflammation and oxidative stress. Heliyon 2020; 6(7): e04422 doi: 10.1016/j.heliyon.2020.e04422
|
| 66 |
Jinchunzi Yang, Neira Sáinz, Elisa Félix-Soriano, Eva Gil-Iturbe, Rosa Castilla-Madrigal, Marta Fernández-Galilea, J. Alfredo Martínez, María J. Moreno-Aliaga. Effects of Long-Term DHA Supplementation and Physical Exercise on Non-Alcoholic Fatty Liver Development in Obese Aged Female Mice. Nutrients 2021; 13(2): 501 doi: 10.3390/nu13020501
|
| 67 |
Ernest C. Lynch, Zhimin Liu, Lin Liu, Xian Wang, Ke K. Zhang, Linglin Xie, Catherine Mounier. Disrupting Osr1 expression promoted hepatic steatosis and inflammation induced by high-fat diet in the mouse model. PLOS ONE 2022; 17(6): e0268344 doi: 10.1371/journal.pone.0268344
|
| 68 |
Yen-Chun Koh, Yen-Cheng Lin, Pei-Sheng Lee, Ting-Jang Lu, Kai-Yi Lin, Min-Hsiung Pan. A multi-targeting strategy to ameliorate high-fat-diet- and fructose-induced (western diet-induced) non-alcoholic fatty liver disease (NAFLD) with supplementation of a mixture of legume ethanol extracts. Food & Function 2020; 11(9): 7545 doi: 10.1039/D0FO01405B
|
| 69 |
Anle Xu, Jingbo Shang-Guan, Zhongbao Li, Zhangfan Huang, Shenjia Shi, Youling Ye. Effects of dietary vitamin E on the growth performance, immunity and digestion of Epinephelus fuscoguttatus ♀ × Epinephelus lanceolatus ♂ by physiology, pathology and RNA-seq. Aquaculture 2023; 575: 739752 doi: 10.1016/j.aquaculture.2023.739752
|
| 70 |
Jiangning Yin, Hanqing Wang, Guoyuan Lu. Umbelliferone alleviates hepatic injury in diabetic db/db mice via inhibiting inflammatory response and activating Nrf2-mediated antioxidant. Bioscience Reports 2018; 38(4) doi: 10.1042/BSR20180444
|
| 71 |
Hung-Jen Lu, Thing-Fong Tzeng, Shorong-Shii Liou, Chia Ju Chang, Cheng Yang, Ming-Chang Wu, I-Min Liu. Ruscogenin Ameliorates Experimental Nonalcoholic Steatohepatitis via Suppressing Lipogenesis and Inflammatory Pathway. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/652680
|
| 72 |
Mengliu Yang, Jihuan Dai, Yanjun Jia, Langquzhen Suo, Shengbing Li, Yunsong Guo, Hua Liu, Ling Li, Gangyi Yang. Overexpression of juxtaposed with another zinc finger gene 1 reduces proinflammatory cytokine release via inhibition of stress‐activated protein kinases and nuclear factor‐κB. The FEBS Journal 2014; 281(14): 3193 doi: 10.1111/febs.12853
|
| 73 |
Teresa Vezza, José Garrido-Mesa, Patricia Diez-Echave, Laura Hidalgo-García, Antonio J. Ruiz-Malagón, Federico García, Manuel Sánchez, Marta Toral, Miguel Romero, Juan Duarte, Enrique Guillamón, Alberto Baños Arjona, Rocío Moron, Julio Galvez, Alba Rodríguez-Nogales, María Elena Rodríguez-Cabezas. Allium-Derived Compound Propyl Propane Thiosulfonate (PTSO) Attenuates Metabolic Alterations in Mice Fed a High-Fat Diet through Its Anti-Inflammatory and Prebiotic Properties. Nutrients 2021; 13(8): 2595 doi: 10.3390/nu13082595
|
| 74 |
Peter P. Sordillo, Laura A. Sordillo. Biophotonics, Tryptophan and Disease. 2022; : 81 doi: 10.1016/B978-0-12-822790-9.00011-5
|
| 75 |
Andra-Iulia Suceveanu, Sergiu-Ioan Micu, Anca Pantea Stoian, Laura Mazilu, Viorel Gherghina, Irinel Raluca Parepa, Adrian-Paul Suceveanu. Essentials of Non-Alcoholic Fatty Liver Disease. 2023; : 59 doi: 10.1007/978-3-031-33548-8_5
|
| 76 |
ZHOU ZHOU, YING-CHAO LIU, XIAO-MEI CHEN, FU-QIANG LI, XIAO-JUAN TONG, YUE-PING DING, CUI-LAN TANG. Treatment of experimental non-alcoholic steatohepatitis by targeting α7 nicotinic acetylcholine receptor-mediated inflammatory responses in mice. Molecular Medicine Reports 2015; 12(5): 6925 doi: 10.3892/mmr.2015.4318
|
| 77 |
Mohamed A. Abdelmegeed, Atrayee Banerjee, Seong-Ho Yoo, Sehwan Jang, Frank J. Gonzalez, Byoung-Joon Song. Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis. Journal of Hepatology 2012; 57(4): 860 doi: 10.1016/j.jhep.2012.05.019
|
| 78 |
Gong‐Rak Lee, Hye In Lee, Narae Kim, Jiae Lee, Minjeong Kwon, Ye Hee Kang, Hyeong Ju Song, Chang‐Yeol Yeo, Woojin Jeong. Dynein light chain LC8 alleviates nonalcoholic steatohepatitis by inhibiting NF‐κB signaling and reducing oxidative stress. Journal of Cellular Physiology 2022; 237(9): 3554 doi: 10.1002/jcp.30811
|
| 79 |
Darmadi Darmadi, Riska Habriel Ruslie. Association between serum interleukin (IL)-12 level and severity of non-alcoholic fatty liver disease (NAFLD). Romanian Journal of Internal Medicine 2021; 59(1): 66 doi: 10.2478/rjim-2020-0029
|
| 80 |
Chong Peng, Jing Li, Xuehong Ke, Fengbin Liu, Ke-er Huang.
In silico
and
in vivo
demonstration of the regulatory mechanism of Qi-Ge decoction in treating NAFLD
. Annals of Medicine 2023; 55(1) doi: 10.1080/07853890.2023.2200258
|
| 81 |
Long Li, Chaoli Duan, Yan Zhao, Xiaofang Zhang, Hongyan Yin, Tianxi Wang, Caoxin Huang, Suhuan Liu, Shuyu Yang, Xuejun Li. Preventive effects of interleukin-6 in lipopolysaccharide/ d -galactosamine induced acute liver injury via regulating inflammatory response in hepatic macrophages. International Immunopharmacology 2017; 51: 99 doi: 10.1016/j.intimp.2017.08.009
|
| 82 |
Roberto Catanzaro, Federica Calabrese, Sergio Occhipinti, Maria Grazia Anzalone, Angelo Italia, Michele Milazzo, Francesco Marotta. Nonalcoholic Fatty Liver Disease Increases Risk for Gastroesophageal Reflux Symptoms. Digestive Diseases and Sciences 2014; 59(8): 1939 doi: 10.1007/s10620-014-3113-7
|
| 83 |
Yanmei Zhang, Xiaoxiao Ge, Yongqing Li, Bingyang Zhang, Peijun Wang, Mingju Hao, Peng Gao, Yueyi Zhao, Tao Sun, Sumei Lu, Wanshan Ma. TWIST2 and the PPAR signaling pathway are important in the progression of nonalcoholic steatohepatitis. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01458-0
|
| 84 |
Edenil Costa Aguilar, Weslley Fernandes-Braga, Paola Caroline Lacerda Leocádio, Gianne Paul Campos, Virginia Soares Lemos, Rafael Pires de Oliveira, Ana Maria Caetano de Faria, Luciano dos Santos Aggum Capettini, Jacqueline I. Alvarez-Leite. Dietary gluten worsens hepatic steatosis by increasing inflammation and oxidative stress in ApoE−/− mice fed a high-fat diet. Food & Function 2023; 14(7): 3332 doi: 10.1039/D3FO00149K
|
| 85 |
Nooshin Yazdani, Seyed Ebrahim Hossini, Mohammad Amin Edalatmanesh. Anti-inflammatory Effect of Aloe vera Extract on Inflammatory Cytokines of Rats Fed with a High-Fat Diet (HFD). Jundishapur Journal of Natural Pharmaceutical Products 2021; 17(1) doi: 10.5812/jjnpp.114323
|
| 86 |
Angeliki Katsarou, Ioannis I Moustakas, Iryna Pyrina, Panagiotis Lembessis, Michael Koutsilieris, Antonios Chatzigeorgiou. Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease. World Journal of Gastroenterology 2020; 26(17): 1993-2011 doi: 10.3748/wjg.v26.i17.1993
|
| 87 |
Laila Naif Al-Harbi, Ghedeir M. Alshammari, Alhanouf Mohammed Al-Dossari, Pandurangan Subash-Babu, Manal Abdulaziz Binobead, Maha H. Alhussain, Sahar Abdulaziz AlSedairy, Doha M. Al-Nouri, Ghalia Shamlan. Beta vulgaris L. (Beetroot) Methanolic Extract Prevents Hepatic Steatosis and Liver Damage in T2DM Rats by Hypoglycemic, Insulin-Sensitizing, Antioxidant Effects, and Upregulation of PPARα. Biology 2021; 10(12): 1306 doi: 10.3390/biology10121306
|
| 88 |
Patricia Diez-Echave, Teresa Vezza, Francesca Algieri, Antonio Jesús Ruiz-Malagón, Laura Hidalgo-García, Federico García, Rocío Morón, Manuel Sánchez, Marta Toral, Miguel Romero, Juan Duarte, José Garrido-Mesa, María Elena Rodríguez-Cabezas, Alba Rodríguez-Nogales, Julio Gálvez. The melatonergic agonist agomelatine ameliorates high fat diet-induced obesity in mice through the modulation of the gut microbiome. Biomedicine & Pharmacotherapy 2022; 153: 113445 doi: 10.1016/j.biopha.2022.113445
|
| 89 |
Min Cheol Kim, Jung Gil Park, Byung Ik Jang, Heon Ju Lee, Won Kee Lee. Liver fibrosis is associated with risk for colorectal adenoma in patients with nonalcoholic fatty liver disease. Medicine 2019; 98(6): e14139 doi: 10.1097/MD.0000000000014139
|
| 90 |
L. E. Tabikhanova, L. P. Osipova, T. V. Churkina, S. S. Kovalev, M. L. Filipenko, E. N. Voronina. Increased Frequencies of ‒174G and ‒572C <i>IL6</i> Alleles in Populations of Indigenous Peoples of Siberia Compared to Russians. Молекулярная биология 2023; 57(2): 350 doi: 10.31857/S0026898423020210
|
| 91 |
Abril Alondra Barrientos-Bonilla, Rasajna Nadella, Paola Belem Pensado-Guevara, Aurora del Carmen Sánchez-García, Laura Mireya Zavala-Flores, Abraham Puga-Olguín, Arnulfo Villanueva-Olivo, Daniel Hernandez-Baltazar. Caspase-3-related apoptosis prevents pathological regeneration in a living liver donor rat model. Advances in Medical Sciences 2021; 66(1): 176 doi: 10.1016/j.advms.2021.02.003
|
| 92 |
Nan Zhu, Xiaoliang Wang, Huiting Zhu, Yue Zheng. Blood cell parameters and risk of nonalcoholic fatty liver disease: a comprehensive Mendelian randomization study. BMC Medical Genomics 2024; 17(1) doi: 10.1186/s12920-024-01879-7
|
| 93 |
Oytun Erbaş, Hüseyin Serdar Akseki, Volkan Solmaz, Hüseyin Aktuğ, Dilek Taşkıran. Fatty liver‐induced changes in stereotypic behavior in rats and effects of glucagon‐like peptide‐1 analog on stereotypy. The Kaohsiung Journal of Medical Sciences 2014; 30(9): 447 doi: 10.1016/j.kjms.2014.05.007
|
| 94 |
Chia Ju Chang, Shorong-Shii Liou, Thing-Fong Tzeng, I-Min Liu. The ethanol extract of Zingiber zerumbet Smith attenuates non-alcoholic fatty liver disease in hamsters fed on high-fat diet. Food and Chemical Toxicology 2014; 65: 33 doi: 10.1016/j.fct.2013.11.048
|
| 95 |
Ik-Rak Jung, Rexford S. Ahima, Sangwon F. Kim. Time-Restricted Feeding Ameliorates Methionine–Choline Deficient Diet-Induced Steatohepatitis in Mice. International Journal of Molecular Sciences 2024; 25(3): 1390 doi: 10.3390/ijms25031390
|
| 96 |
Dürdane Aksoy, Volkan Solmaz, Dilek Taşkıran, Oytun Erbaş. The association between seizure predisposition and inflammation in a rat model of fatty liver disease. Neurological Sciences 2014; 35(9): 1441 doi: 10.1007/s10072-014-1778-5
|
| 97 |
Songpei Li, Xiao-Yi Zeng, Xiu Zhou, Hao Wang, Eunjung Jo, Stephen R. Robinson, Aimin Xu, Ji-Ming Ye. Dietary cholesterol induces hepatic inflammation and blunts mitochondrial function in the liver of high-fat-fed mice. The Journal of Nutritional Biochemistry 2016; 27: 96 doi: 10.1016/j.jnutbio.2015.08.021
|
| 98 |
Safa Tahmasebi, Hassan Neishaboori, Davood Jafari, Elham Faghihzadeh, Abdolreza Esmaeilzadeh, Abbas Mirshafiey. The effects of guluronic acid (G2013), a new emerging treatment, on inflammatory factors in nonalcoholic steatohepatitis patients under in vitro conditions. Immunopharmacology and Immunotoxicology 2021; 43(5): 562 doi: 10.1080/08923973.2021.1954946
|
| 99 |
Savinda Liyanagedera, Robert Patrick Williams, Silvio Veraldi, Valerio Nobili, Jake P. Mann. The pharmacological management of NAFLD in children and adolescents. Expert Review of Clinical Pharmacology 2017; 10(11): 1225 doi: 10.1080/17512433.2017.1365599
|
| 100 |
I. V. Kurbatova, L. V. Topchieva, O. P. Dudanova. Gene TNF Polymorphism -308G>A (rs1800629) and Its Relationship with the Efficiency of Ursodeoxycholic Acid Therapy in Patients with Nonalcoholic Stetohepatitis. Bulletin of Experimental Biology and Medicine 2017; 164(2): 181 doi: 10.1007/s10517-017-3953-1
|
| 101 |
Joost Boeckmans, Alessandra Natale, Karolien Buyl, Vera Rogiers, Joery De Kock, Tamara Vanhaecke, Robim M. Rodrigues. Human-based systems: Mechanistic NASH modelling just around the corner?. Pharmacological Research 2018; 134: 257 doi: 10.1016/j.phrs.2018.06.029
|
| 102 |
Chigusa Kikuchi, Akiko Sakasai-Sakai, Risa Okimura, Hinako Tanaka, Takanobu Takata, Masayoshi Takeuchi, Tamihide Matsunaga. Accumulation of Toxic Advanced Glycation End-Products Induces Cytotoxicity and Inflammation in Hepatocyte-Like Cells Differentiated from Human Induced Pluripotent Stem Cells. Biological and Pharmaceutical Bulletin 2021; 44(10): 1399 doi: 10.1248/bpb.b21-00520
|
| 103 |
Pallavi Subramanian, Jochen Hampe, Frank Tacke, Triantafyllos Chavakis. Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD). International Journal of Molecular Sciences 2022; 23(13): 6996 doi: 10.3390/ijms23136996
|
| 104 |
Karmin O, Connie W.H. Woo, Victoria Sid, Yaw L. Siow. Molecular Nutrition. 2020; : 323 doi: 10.1016/B978-0-12-811907-5.00028-2
|
| 105 |
Jung-Pyo Yang, Ji-Hun Shin, Seung-Hwan Seo, Sang-Gyun Kim, Sang Hyung Lee, Eun-Hee Shin. Effects of Antioxidants in Reducing Accumulation of Fat in Hepatocyte. International Journal of Molecular Sciences 2018; 19(9): 2563 doi: 10.3390/ijms19092563
|
| 106 |
Nathalia Soares da Cruz, Gabriel Pasquarelli-do-Nascimento, Augusto Cézar Polveiro e Oliveira, Kelly Grace Magalhães. Inflammasome-Mediated Cytokines: A Key Connection between Obesity-Associated NASH and Liver Cancer Progression. Biomedicines 2022; 10(10): 2344 doi: 10.3390/biomedicines10102344
|
| 107 |
Xiang Tao, Haiqing He, Jiangtong Peng, Rui Xu, Jing Fu, Yuting Hu, Li Li, Xiaoyan Yang, Xiuling Feng, Chao Zhang, Lingmin Zhang, Xiyong Yu, Ao Shen, Kai Huang, Qin Fu. Overexpression of PDE4D in mouse liver is sufficient to trigger NAFLD and hypertension in a CD36-TGF-β1 pathway: therapeutic role of roflumilast. Pharmacological Research 2022; 175: 106004 doi: 10.1016/j.phrs.2021.106004
|
| 108 |
Abdo Mahli, Michael Saugspier, Andreas Koch, Judith Sommer, Peter Dietrich, Seren Lee, Reinhard Thasler, Jan Schulze-Luehrmann, Anja Luehrmann, Wolfgang Erwin Thasler, Martina Müller, Anja Bosserhoff, Claus Hellerbrand. ERK activation and autophagy impairment are central mediators of irinotecan-induced steatohepatitis. Gut 2017; : gutjnl-2016-312485 doi: 10.1136/gutjnl-2016-312485
|
| 109 |
L. V. Topchieva, I. V. Kurbatova, O. P. Dudanova, A. A. Sokolovskaya, A. A. Shipovskaya.
IL6R Gene Polymorphic Variant rs2228145(C >A) as a Marker of Genetic Liability to Nonalcoholic Steatohepatitis in the Russian Population of Karelia. Bulletin of Experimental Biology and Medicine 2018; 165(1): 64 doi: 10.1007/s10517-018-4100-3
|
| 110 |
Feng Tian, Ya Jie Zhang, Yu Li, Ying Xie, Yu Wang. Celecoxib Ameliorates Non-Alcoholic Steatohepatitis in Type 2 Diabetic Rats via Suppression of the Non-Canonical Wnt Signaling Pathway Expression. PLoS ONE 2014; 9(1): e83819 doi: 10.1371/journal.pone.0083819
|
| 111 |
Элеонора Николаевна Трушина. ABOUT THE MECHANISMS OF THE PROTECTIVE INFLUENCE OF CARNOSINE IN NON-ALCOHOLIC FATTY LIVER DISEASE. Наука. Исследования. Практика: сборник избранных статей по материалам Международной научной конференции (Санкт-Петербург, Декабрь 2021) 2022; : 35 doi: 10.37539/SRP300.2021.75.64.005
|
| 112 |
Larisse Longo, Josimar Macedo de Castro, Melina Belén Keingeski, Pabulo Henrique Rampelotto, Dirson João Stein, Gabriel Tayguara Silveira Guerreiro, Valessa Emanoele Gabriel de Souza, Carlos Thadeu Schmidt Cerski, Carolina Uribe-Cruz, Iraci L.S. Torres, Mário Reis Álvares-da-Silva. Nicotinamide riboside and dietary restriction effects on gut microbiota and liver inflammatory and morphologic markers in cafeteria diet–induced obesity in rats. Nutrition 2023; 110: 112019 doi: 10.1016/j.nut.2023.112019
|
| 113 |
Pawel A. Kolodziejski, Natalia Leciejewska, Agata Chmurzynska, Maciej Sassek, Aleksandra Szczepankiewicz, Dawid Szczepankiewicz, Emilian Malek, Mathias Z. Strowski, Zuzanna Checinska-Maciejewska, Krzysztof W. Nowak, Ewa Pruszynska-Oszmalek. 30-Day spexin treatment of mice with diet-induced obesity (DIO) and type 2 diabetes (T2DM) increases insulin sensitivity, improves liver functions and metabolic status. Molecular and Cellular Endocrinology 2021; 536: 111420 doi: 10.1016/j.mce.2021.111420
|
| 114 |
I. V. Kurbatova, L. V. Topchieva, O. P. Dudanova. Caspase 3, 6, 8, and 9 Gene Expression in Peripheral Blood Leukocytes and Plasma Concentrations of IL-6 and TNF-α in Carriers of Different Polymorphic Marker -174G>C Genotypes of IL6 Gene Associated with the Risk of Nonalcoholic Steatohepatitis. Bulletin of Experimental Biology and Medicine 2017; 162(3): 370 doi: 10.1007/s10517-017-3618-0
|
| 115 |
Peng Song, Junbin Zhang, Yunwei Zhang, Zhiping Shu, Peng Xu, Long He, Chao Yang, Jinxiang Zhang, Hui Wang, Yiqing Li, Qin Li. Hepatic recruitment of CD11b+Ly6C+ inflammatory monocytes promotes hepatic ischemia/reperfusion injury. International Journal of Molecular Medicine 2017; doi: 10.3892/ijmm.2017.3315
|
| 116 |
Mary P. Moore, Rory P. Cunningham, Rachel A. H. Davis, Sarah E. Deemer, Brandon M. Roberts, Eric P. Plaisance, R. Scott Rector. A dietary ketone ester mitigates histological outcomes of NAFLD and markers of fibrosis in high-fat diet fed mice. American Journal of Physiology-Gastrointestinal and Liver Physiology 2021; 320(4): G564 doi: 10.1152/ajpgi.00259.2020
|
| 117 |
Fu Chen, Yong Zhou, Zhiyuan Wu, Yunze Li, Wenlong Zhou, Yong Wang. Integrated Analysis of Key Genes and Pathways Involved in Nonalcoholic Steatohepatitis Improvement After Roux-en-Y Gastric Bypass Surgery. Frontiers in Endocrinology 2021; 11 doi: 10.3389/fendo.2020.611213
|
| 118 |
Patrice Marques, Vera Francisco, Laura Martínez-Arenas, Ângela Carvalho-Gomes, Elena Domingo, Laura Piqueras, Marina Berenguer, Maria-Jesus Sanz. Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2023; 24(3): 2313 doi: 10.3390/ijms24032313
|
| 119 |
Meenakshi Vachher, Savita Bansal, Bhupender Kumar, Sandeep Yadav, Taruna Arora, Nalini Moza Wali, Archana Burman. Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma. Journal of Cellular Biochemistry 2022; 123(10): 1553 doi: 10.1002/jcb.30252
|
| 120 |
Ilias D. Vachliotis, Ioannis Valsamidis, Stergios A. Polyzos. Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma. Cancers 2023; 15(21): 5306 doi: 10.3390/cancers15215306
|
| 121 |
H M Kim, B R Lee, E S Lee, M H Kwon, J H Huh, B-E Kwon, E-K Park, S-Y Chang, M-N Kweon, P-H Kim, H-J Ko, C H Chung. iNKT cells prevent obesity-induced hepatic steatosis in mice in a C-C chemokine receptor 7-dependent manner. International Journal of Obesity 2018; 42(2): 270 doi: 10.1038/ijo.2017.200
|
| 122 |
Mayada Metwally, Mohammed Eslam, Jacob George. Genetic and Epigenetic Associations of NAFLD: Focus on Clinical Decision Making. Current Hepatology Reports 2017; 16(4): 335 doi: 10.1007/s11901-017-0372-8
|
| 123 |
Dong Ji, Gregory Cheng, George Lau. Reply to: “NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – The debate continues”. Journal of Hepatology 2021; 74(2): 484 doi: 10.1016/j.jhep.2020.10.020
|
| 124 |
Mojtaba Rashidi, Reza Afarin, Maryam Kouchak, Benyamin Kabizadeh, Masoumeh Shamsi, Mahdi Hatami. Resveratrol and Saroglitazar: A Promising Combination for Targeting TGF-β/Smad3 Signaling and Attenuating Inflammatory Response in Nonalcoholic Steatohepatitis in Rats. Hepatitis Monthly 2023; 23(1) doi: 10.5812/hepatmon-138237
|
| 125 |
David J. Orlicky, Andrew E. Libby, Elise S. Bales, Rachel H. McMahan, Jenifer Monks, Francisco G. La Rosa, James L. McManaman. Perilipin‐2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra‐hepatocyte actions. The Journal of Physiology 2019; 597(6): 1565 doi: 10.1113/JP277140
|
| 126 |
I V Kurbatova, L V Topchieva, O P Dudanova, A A Shipovskaya. Biochemical and molecular-genetic indicators of inflammation and apoptosis in liver cirrhosis as an outcome of the progression of non-alcoholic steatohepatitis. Terapevticheskii arkhiv 2019; 91(4): 21 doi: 10.26442/00403660.2019.04.000057
|
| 127 |
Eva Peterová, Lucie Podmolíková, Martina Řezáčová, Alena Mrkvicová. Fibroblast Growth Factor-1 Suppresses TGF-β-Mediated Myofibroblastic Differentiation of Rat Hepatic Stellate Cells. Acta Medica (Hradec Kralove, Czech Republic) 2016; 59(4): 124 doi: 10.14712/18059694.2017.39
|
| 128 |
William K. K. Wu, Lin Zhang, Matthew T. V. Chan. Obesity, Fatty Liver and Liver Cancer. Advances in Experimental Medicine and Biology 2018; 1061: 127 doi: 10.1007/978-981-10-8684-7_10
|
| 129 |
A. MORAVCOVÁ, Z. ČERVINKOVÁ, O. KUČERA, V. MEZERA, D. RYCHTRMOC, H. LOTKOVÁ. The Effect of Oleic and Palmitic Acid on Induction of Steatosis and Cytotoxicity on Rat Hepatocytes in Primary Culture. Physiological Research 2015; : S627 doi: 10.33549/physiolres.933224
|
| 130 |
Vettickattuparambil George Giby, Thekkuttuparambil Ananthanarayanan Ajith. Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver disease. World Journal of Hepatology 2014; 6(8): 570-579 doi: 10.4254/wjh.v6.i8.570
|
| 131 |
Dong Ji, Mingjie Zhang, Enqiang Qin, Lunqing Zhang, Jing Xu, Yudong Wang, Gregory Cheng, Feng Wang, George Lau. Letter to the Editor: Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19. Metabolism 2021; 115: 154437 doi: 10.1016/j.metabol.2020.154437
|
| 132 |
Charles I. V. Drummer, Fatma Saaoud, Yu Sun, Diana Atar, Keman Xu, Yifan Lu, Ying Shao, Candice Johnson, Lu Liu, Huimin Shen, Nirag C. Jhala, Xiaohua Jiang, Hong Wang, Xiaofeng Yang, Baohui Xu. Hyperlipidemia May Synergize with Hypomethylation in Establishing Trained Immunity and Promoting Inflammation in NASH and NAFLD. Journal of Immunology Research 2021; 2021: 1 doi: 10.1155/2021/3928323
|
| 133 |
Jun-Qi Shi, Wen-Xia Shen, Xiang-Zhi Wang, Ke Huang, Chao-Chun Zou. Relationship between immune parameters and non-alcoholic fatty liver disease in obese children. Indian Pediatrics 2017; 54(10): 825 doi: 10.1007/s13312-017-1143-x
|
| 134 |
Natalie Stiglund, Hannes Hagström, Per Stål, Martin Cornillet, Niklas K. Björkström. Dysregulated peripheral proteome reveals NASH-specific signatures identifying patient subgroups with distinct liver biology. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1186097
|
| 135 |
Rongrong Zhou, Xuegong Fan, Bernd Schnabl. Role of the intestinal microbiome in liver fibrosis development and new treatment strategies. Translational Research 2019; 209: 22 doi: 10.1016/j.trsl.2019.02.005
|
| 136 |
Mei-Ling Su, Yu He, Qi-Sen Li, Bang-Hao Zhu. Efficacy of Acetylshikonin in Preventing Obesity and Hepatic Steatosis in db/db Mice. Molecules 2016; 21(8): 976 doi: 10.3390/molecules21080976
|
| 137 |
Jharna Puppala, Siva Prasad Siddapuram, Jyothy Akka, Anjana Munshi. Genetics of Nonalcoholic Fatty Liver Disease: An Overview. Journal of Genetics and Genomics 2013; 40(1): 15 doi: 10.1016/j.jgg.2012.12.001
|
| 138 |
Shari S. Rogal, Klaus Bielefeldt, Ajay D. Wasan, Eva Szigethy, Francis Lotrich, Andrea F. DiMartini. Fibromyalgia Symptoms and Cirrhosis. Digestive Diseases and Sciences 2015; 60(5): 1482 doi: 10.1007/s10620-014-3453-3
|
| 139 |
Shoumo Bhattacharya, Akane Kawamura. Inflammatory Disorders, Part A. Advances in Protein Chemistry and Structural Biology 2020; 119: 1 doi: 10.1016/bs.apcsb.2019.09.003
|
| 140 |
Ayokanmi Ore, Oluseyi Adeboye Akinloye, Abideen Idowu Adeogun, Regina Ngozi Ugbaja, Eric Morifi, Maya Makatini, Refilwe Moepya, Thapelo Mbhele.
Buchholzia coriacea
seed (wonderful kolanut) alleviates insulin resistance, steatosis, inflammation and oxidative stress in high fat diet model of fatty liver disease
. Journal of Food Biochemistry 2022; 46(3) doi: 10.1111/jfbc.13836
|
| 141 |
Ding‐You Li, Min Yang, Sarah Edwards, Shui‐Qing Ye. Nonalcoholic Fatty Liver Disease. Journal of Parenteral and Enteral Nutrition 2013; 37(6): 787 doi: 10.1177/0148607113481623
|
| 142 |
Yoshihisa Takahashi, Keiichiro Sugimoto, Yurie Soejima, Arisa Kumagai, Tatsuki Koeda, Aiko Shojo, Kazuya Nakagawa, Naoki Harada, Ryoichi Yamaji, Hiroshi Inui, Toshikazu Yamanouchi, Toshio Fukusato. Inhibitory Effects of Eucalyptus and Banaba Leaf Extracts on Nonalcoholic Steatohepatitis Induced by a High-Fructose/High-Glucose Diet in Rats. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/296207
|
| 143 |
Ji-Su Ahn, Ji Won Yang, Su-Jeong Oh, Ye Young Shin, Min-Jung Kang, Hae Ryoun Park, Yoojin Seo, Hyung-Sik Kim. Porphyromonas gingivalis exacerbates the progression of fatty liver disease via CD36-PPARγ pathway. BMB Reports 2021; 54(6): 323 doi: 10.5483/BMBRep.2021.54.6.050
|
| 144 |
Deepika Kumari, Jyoti Gautam, Vipin Sharma, Sonu Kumar Gupta, Soumalya Sarkar, Pradipta Jana, Vikas Singhal, Prabhakar Babele, Parul Kamboj, Sneh Bajpai, Ruchi Tandon, Yashwant Kumar, Madhu Dikshit. Effect of herbal extracts and Saroglitazar on high-fat diet-induced obesity, insulin resistance, dyslipidemia, and hepatic lipidome in C57BL/6J mice. Heliyon 2023; 9(11): e22051 doi: 10.1016/j.heliyon.2023.e22051
|
| 145 |
Atul Goyale, Anjly Jain, Colette Smith, Margarita Papatheodoridi, Marta Guerrero Misas, Davide Roccarina, Laura Iogna Prat, Dimitri P. Mikhailidis, Devaki Nair, Emmanuel Tsochatzis, Pavel Strnad. Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study. PLOS ONE 2021; 16(11): e0260313 doi: 10.1371/journal.pone.0260313
|
| 146 |
M. Elaine Husni. Comorbidities in Psoriatic Arthritis. Rheumatic Disease Clinics of North America 2015; 41(4): 677 doi: 10.1016/j.rdc.2015.07.008
|
| 147 |
Francislaine AR Lívero, Alexandra Acco. Molecular basis of alcoholic fatty liver disease: From incidence to treatment. Hepatology Research 2016; 46(1): 111 doi: 10.1111/hepr.12594
|
| 148 |
Francesco Bellanti, Gianluigi Vendemiale. Coronavirus disease 2019 and non-alcoholic fatty liver disease. World Journal of Hepatology 2021; 13(9): 969-978 doi: 10.4254/wjh.v13.i9.969
|
| 149 |
Chuxin Huang, Jiali Qian, Ying Liu, Li Zhang, Yehong Yang. Empagliflozin attenuates liver fibrosis in high‐fat diet/streptozotocin‐induced mice by modulating gut microbiota. Clinical and Experimental Pharmacology and Physiology 2024; 51(3) doi: 10.1111/1440-1681.13842
|
| 150 |
Yeon-Hui Jeong, Haeng Hur, Eun-Joo Jeon, Su-Jin Park, Jin Hwang, Ae Lee, Kyong Lee, Mi Sung. Honokiol Improves Liver Steatosis in Ovariectomized Mice. Molecules 2018; 23(1): 194 doi: 10.3390/molecules23010194
|
| 151 |
Martha D. Gay, Anita Safronenka, Hong Cao, Felice H. Liu, Zoe X. Malchiodi, Robin D. Tucker, Alexander Kroemer, Narayan Shivapurkar, Jill P. Smith. Targeting the Cholecystokinin Receptor: A Novel Approach for Treatment and Prevention of Hepatocellular Cancer. Cancer Prevention Research 2021; 14(1): 17 doi: 10.1158/1940-6207.CAPR-20-0220
|
| 152 |
Kangkang Yin, Xiao Zhou, Wei Jiang, Linlin Wang, Ziwei Dai, Biao Tang, Gaetano Isola. Jiangzhi Ligan Decoction Inhibits GSDMD-Mediated Canonical/Noncanonical Pyroptosis Pathways and Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease. Disease Markers 2021; 2021: 1 doi: 10.1155/2021/9963534
|
| 153 |
Pratibha Gaur, Marcin Cebula, Mathias Riehn, Upneet Hillebrand, Hansjörg Hauser, Dagmar Wirth. Diet induced obesity has an influence on intrahepatic T cell responses. Metabolism 2017; 69: 171 doi: 10.1016/j.metabol.2017.01.022
|
| 154 |
Baran Ghezelbash, Nader Shahrokhi, Mohammad Khaksari, Gholamreza Asadikaram, Maryam Shahrokhi, Sara Shirazpour. Protective Roles of Shilajit in Modulating Resistin, Adiponectin, and Cytokines in Rats with Non-alcoholic Fatty Liver Disease. Chinese Journal of Integrative Medicine 2022; 28(6): 531 doi: 10.1007/s11655-022-3307-3
|
| 155 |
Yufang Ding, Karin Yanagi, Fang Yang, Evelyn Callaway, Clint Cheng, Martha E Hensel, Rani Menon, Robert C Alaniz, Kyongbum Lee, Arul Jayaraman. Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice. eLife 2024; 12 doi: 10.7554/eLife.87458.3
|
| 156 |
Aleksander Danikiewicz, Bartosz Hudzik, Justyna Nowak, Joanna Kowalska, Iwona Zieleń-Zynek, Janusz Szkodzinski, Han Naung Tun, Barbara Zubelewicz-Szkodzinska. Serum Gamma Glutamyltransferase Is Associated with 25-Hydroxyvitamin D Status in Elderly Patients with Stable Coronary Artery Disease. International Journal of Environmental Research and Public Health 2020; 17(23): 8980 doi: 10.3390/ijerph17238980
|
| 157 |
Masoumeh Norouzpour, Sayed Mohammad Marandi, Mohsen Ghanbarzadeh, Abbasali Zare Maivan. Response of Inflammatory Biomarkers to 10 Weeks of Aerobic Resistance Training in Inactive Postmenopausal Women with Non-alcoholic Fatty Liver. Jundishapur Journal of Chronic Disease Care 2021; 10(3) doi: 10.5812/jjcdc.114163
|
| 158 |
Hironori Kitade, Guanliang Chen, Yinhua Ni, Tsuguhito Ota. Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments. Nutrients 2017; 9(4): 387 doi: 10.3390/nu9040387
|
| 159 |
Maisa Mahmoud Ali Kamkar, Rasheed Ahmad, Osama Alsmadi, Kazem Behbehani. Insight into the impact of diabetes mellitus on the increased risk of hepatocellular carcinoma: mini-review. Journal of Diabetes & Metabolic Disorders 2014; 13(1) doi: 10.1186/2251-6581-13-57
|
| 160 |
Li Qin, Junru Wu, Xuejing Sun, Xuewei Huang, Wei Huang, Chunyan Weng, Jingjing Cai. The regulatory role of metabolic organ-secreted factors in the nonalcoholic fatty liver disease and cardiovascular disease. Frontiers in Cardiovascular Medicine 2023; 10 doi: 10.3389/fcvm.2023.1119005
|
| 161 |
Sen Zhang, Wu-Yi Sun, Jing-Jing Wu, Wei Wei. TGF-β signaling pathway as a pharmacological target in liver diseases. Pharmacological Research 2014; 85: 15 doi: 10.1016/j.phrs.2014.05.005
|
| 162 |
Zhisheng Her, Joel Heng Loong Tan, Yee-Siang Lim, Sue Yee Tan, Xue Ying Chan, Wilson Wei Sheng Tan, Min Liu, Kylie Su Mei Yong, Fritz Lai, Erica Ceccarello, Zhiqiang Zheng, Yong Fan, Kenneth Tou En Chang, Lei Sun, Shih Chieh Chang, Chih-Liang Chin, Guan Huei Lee, Yock Young Dan, Yun-Shen Chan, Seng Gee Lim, Jerry Kok Yen Chan, K. George Chandy, Qingfeng Chen. CD4+ T Cells Mediate the Development of Liver Fibrosis in High Fat Diet-Induced NAFLD in Humanized Mice. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.580968
|
| 163 |
Nada Pejnovic, Ilija Jeftic, Nemanja Jovicic, Nebojsa Arsenijevic, Miodrag L Lukic. Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis. World Journal of Gastroenterology 2016; 22(44): 9706-9717 doi: 10.3748/wjg.v22.i44.9706
|
| 164 |
Pratima Dibba, Andrew A Li, George Cholankeril, Muhammad Ali Khan, Donghee Kim, Aijaz Ahmed. Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary. Nutrition and Metabolic Insights 2019; 12: 117863881984748 doi: 10.1177/1178638819847480
|
| 165 |
Amandeep Singh Arora, Saima Zafar, Umair Latif, Franc Llorens, Sabine Mihm, Prateek Kumar, Waqas Tahir, Katrin Thüne, Mohsin Shafiq, Matthias Schmitz, Inga Zerr. The role of cellular prion protein in lipid metabolism in the liver. Prion 2020; 14(1): 95 doi: 10.1080/19336896.2020.1729074
|
| 166 |
Akshatha N. Srinivas, Diwakar Suresh, Prasanna K. Santhekadur, Deepak Suvarna, Divya P. Kumar. Extracellular Vesicles as Inflammatory Drivers in NAFLD. Frontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.627424
|
| 167 |
Alexander Wree, Matthew D. McGeough, Maria Eugenia Inzaugarat, Akiko Eguchi, Susanne Schuster, Casey D. Johnson, Carla A. Peña, Lukas J. Geisler, Bettina G. Papouchado, Hal M. Hoffman, Ariel E. Feldstein. NLRP3 inflammasome driven liver injury and fibrosis: Roles of IL‐17 and TNF in mice. Hepatology 2018; 67(2): 736 doi: 10.1002/hep.29523
|
| 168 |
Guy Bower, Thanos Athanasiou, Alberto M. Isla, Leanne Harling, Jia V. Li, Elaine Holmes, Evangelos Efthimiou, Ara Darzi, Hutan Ashrafian. Bariatric surgery and nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2015; 27(7): 755 doi: 10.1097/MEG.0000000000000375
|
| 169 |
Aldo Lagomarsino. Liver regeneration in nonalcoholic fatty liver disease. Medwave 2012; 12(11): e5559 doi: 10.5867/medwave.2012.11.5559
|
| 170 |
Kyu-Hyouck Kyoung, Sung-Gyu Lee, Shin Hwang, Ki-Hun Kim, Suk-Kyung Hong. Liver Steatosis in Brain-Dead Donors: Progression Pattern and Affecting Factors. Transplantation Proceedings 2020; 52(5): 1318 doi: 10.1016/j.transproceed.2020.02.161
|
| 171 |
Yuan Yao, Yunfeng Shen. Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target. Open Life Sciences 2023; 18(1) doi: 10.1515/biol-2022-0699
|
| 172 |
Soo Lim, Tae Jung Oh, Kwang Kon Koh. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders. International Journal of Cardiology 2015; 201: 408 doi: 10.1016/j.ijcard.2015.08.107
|
| 173 |
Yoshihisa Takahashi, Yurie Soejima, Arisa Kumagai, Masato Watanabe, Hiroshi Uozaki, Toshio Fukusato, Kalpana Ghoshal. Inhibitory Effects of Japanese Herbal Medicines Sho-saiko-to and Juzen-taiho-to on Nonalcoholic Steatohepatitis in Mice. PLoS ONE 2014; 9(1): e87279 doi: 10.1371/journal.pone.0087279
|
| 174 |
Chia-Chu Chang, Chia-Lin Wu, Wei-Wen Su, Kai-Lun Shih, Der-Cherng Tarng, Chen-Te Chou, Ting-Yu Chen, Chew-Teng Kor, Hung-Ming Wu. Interferon gamma-induced protein 10 is associated with insulin resistance and incident diabetes in patients with nonalcoholic fatty liver disease. Scientific Reports 2015; 5(1) doi: 10.1038/srep10096
|
| 175 |
Vishal Patel, Amit Joharapurkar, Samadhan Kshirsagar, Brijesh Sutariya, Maulik Patel, Dheerendra Pandey, Hiren Patel, Ramchandra Ranvir, Shekhar Kadam, Dipam Patel, Rajesh Bahekar, Mukul Jain. Coagonist of GLP-1 and glucagon decreases liver inflammation and atherosclerosis in dyslipidemic condition. Chemico-Biological Interactions 2018; 282: 13 doi: 10.1016/j.cbi.2018.01.004
|
| 176 |
Douglas M Oswald, Mark B Jones, Brian A Cobb. Modulation of hepatocyte sialylation drives spontaneous fatty liver disease and inflammation. Glycobiology 2020; 30(5): 346 doi: 10.1093/glycob/cwz096
|
| 177 |
Helda Tutunchi, Farideh Zolrahim, Mahlagha Nikbaf-Shandiz, Fatemeh Naeini, Alireza Ostadrahimi, Sina Naghshi, Reza Salek, Farzad Najafipour. Effects of oleoylethanolamide supplementation on inflammatory biomarkers, oxidative stress and antioxidant parameters of obese patients with NAFLD on a calorie-restricted diet: A randomized controlled trial. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1144550
|
| 178 |
Kerstin Knoop, Nathalie Schwenk, Patrick Dolp, Michael J. Willhauck, Christoph Zischek, Christian Zach, Markus Hacker, Burkhard Göke, Ernst Wagner, Peter J. Nelson, Christine Spitzweg. Stromal Targeting of Sodium Iodide Symporter Using Mesenchymal Stem Cells Allows Enhanced Imaging and Therapy of Hepatocellular Carcinoma. Human Gene Therapy 2013; 24(3): 306 doi: 10.1089/hum.2012.104
|
| 179 |
Yaping Wang, Xiaobo Li, Shunlin Ren. Cholesterol Metabolites 25-Hydroxycholesterol and 25-Hydroxycholesterol 3-Sulfate Are Potent Paired Regulators: From Discovery to Clinical Usage. Metabolites 2020; 11(1): 9 doi: 10.3390/metabo11010009
|
| 180 |
Sara Arefhosseini, Helda Tutunchi, Solmaz Nomi-Golzar, Soltanali Mahboob, Zohre Pouretedal, Mehrangiz Ebrahimi-Mameghani. The effect of hydroxy citric acid supplementation with calorie-restricted diet on metabolic, atherogenic and inflammatory biomarkers in women with non-alcoholic fatty liver disease: a randomized controlled clinical trial. Food & Function 2022; 13(9): 5124 doi: 10.1039/D1FO03685H
|
| 181 |
Sanja Stojsavljević, Marija Gomerčić Palčić, Lucija Virović Jukić, Lea Smirčić Duvnjak, Marko Duvnjak. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(48): 18070-18091 doi: 10.3748/wjg.v20.i48.18070
|
| 182 |
Ki Wung Chung, Ye Eun Cho, Seung-Jin Kim, Seonghwan Hwang. Immune-related pathogenesis and therapeutic strategies of nonalcoholic steatohepatitis. Archives of Pharmacal Research 2022; 45(4): 229 doi: 10.1007/s12272-022-01379-1
|
| 183 |
Ursa Kovac, Damjana Rozman. Encyclopedia of Life Sciences. 2015; : 1 doi: 10.1002/9780470015902.a0025335
|
| 184 |
Klaudia Berk, Wiktor Bzdega, Karolina Konstantynowicz-Nowicka, Tomasz Charytoniuk, Hubert Zywno, Adrian Chabowski. Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment. Journal of Clinical Medicine 2021; 10(3): 393 doi: 10.3390/jcm10030393
|
| 185 |
Nikos Stratakis, Lucy Golden‐Mason, Katerina Margetaki, Yinqi Zhao, Damaskini Valvi, Erika Garcia, Léa Maitre, Sandra Andrusaityte, Xavier Basagana, Eva Borràs, Mariona Bustamante, Maribel Casas, Serena Fossati, Regina Grazuleviciene, Line Småstuen Haug, Barbara Heude, Rosemary R.C. McEachan, Helle Margrete Meltzer, Eleni Papadopoulou, Theano Roumeliotaki, Oliver Robinson, Eduard Sabidó, Jose Urquiza, Marina Vafeiadi, Nerea Varo, John Wright, Miriam B. Vos, Howard Hu, Martine Vrijheid, Kiros T. Berhane, David V. Conti, Rob McConnell, Hugo R. Rosen, Lida Chatzi. In Utero Exposure to Mercury Is Associated With Increased Susceptibility to Liver Injury and Inflammation in Childhood. Hepatology 2021; 74(3): 1546 doi: 10.1002/hep.31809
|
| 186 |
Rasoul Akbari, Tahereh Behdarvand, Reza Afarin, Hamid Yaghooti, Mohammad Taha Jalali, Narges Mohammadtaghvaei. Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis. BMC Pharmacology and Toxicology 2021; 22(1) doi: 10.1186/s40360-021-00524-8
|
| 187 |
Adil Mardinoglu, Hao Wu, Elias Bjornson, Cheng Zhang, Antti Hakkarainen, Sari M. Räsänen, Sunjae Lee, Rosellina M. Mancina, Mattias Bergentall, Kirsi H. Pietiläinen, Sanni Söderlund, Niina Matikainen, Marcus Ståhlman, Per-Olof Bergh, Martin Adiels, Brian D. Piening, Marit Granér, Nina Lundbom, Kevin J. Williams, Stefano Romeo, Jens Nielsen, Michael Snyder, Mathias Uhlén, Göran Bergström, Rosie Perkins, Hanns-Ulrich Marschall, Fredrik Bäckhed, Marja-Riitta Taskinen, Jan Borén. An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans. Cell Metabolism 2018; 27(3): 559 doi: 10.1016/j.cmet.2018.01.005
|
| 188 |
Oliver Glass, Ricardo Henao, Keyur Patel, Cynthia D. Guy, Hans J. Gruss, Wing‐Kin Syn, Cynthia A. Moylan, Robert Streilein, Russell Hall, Anna Mae Diehl, Manal F. Abdelmalek. Serum Interleukin‐8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Hepatology Communications 2018; 2(11): 1344 doi: 10.1002/hep4.1237
|
| 189 |
Carlotta Hoffmann, Philipp A. Gerber, Claudia Cavelti-Weder, Louisa Licht, Reham Kotb, Rania Al Dweik, Michele Cherfane, Stefan R. Bornstein, Nikolaos Perakakis. Liver, NAFLD and COVID-19. Hormone and Metabolic Research 2022; 54(08): 522 doi: 10.1055/a-1834-9008
|
| 190 |
Michael J. Duryee, Monte S. Willis, Courtney S. Schaffert, Roger D. Reidelberger, Anand Dusad, Daniel R. Anderson, Lynell W. Klassen, Geoffrey M. Thiele. Precision-cut liver slices from diet-induced obese rats exposed to ethanol are susceptible to oxidative stress and increased fatty acid synthesis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2014; 306(3): G208 doi: 10.1152/ajpgi.00124.2013
|
| 191 |
Zhenwei Gong, Emir Tas, Shoshana Yakar, Radhika Muzumdar. Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging. Molecular and Cellular Endocrinology 2017; 455: 115 doi: 10.1016/j.mce.2016.12.022
|
| 192 |
Fanping Meng, Yao Lin, Min Yang, Minyan Li, Gangyi Yang, Po Hao, Ling Li. JAZF1 Inhibits Adipose Tissue Macrophages and Adipose Tissue Inflammation in Diet-Induced Diabetic Mice. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/4507659
|
| 193 |
Tomasz Kostrzewski, Terri Cornforth, Sophie A Snow, Larissa Ouro-Gnao, Cliff Rowe, Emma M Large, David J Hughes. Three-dimensional perfused human <i>in vitro</i> model of non-alcoholic fatty liver disease. World Journal of Gastroenterology 2017; 23(2): 204-215 doi: 10.3748/wjg.v23.i2.204
|
| 194 |
Natalia de las Heras, María Valero-Muñoz, Beatriz Martín-Fernández, Sandra Ballesteros, Antonio López-Farré, Baltasar Ruiz-Roso, Vicente Lahera. Molecular factors involved in the hypolipidemic- and insulin-sensitizing effects of a ginger (Zingiber officinale Roscoe) extract in rats fed a high-fat diet. Applied Physiology, Nutrition, and Metabolism 2017; 42(2): 209 doi: 10.1139/apnm-2016-0374
|
| 195 |
Abdullah S. Shatoor, Suliman Al Humayed, Hussain M. Almohiy. Astaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2. Journal of Physiology and Biochemistry 2022; 78(1): 151 doi: 10.1007/s13105-021-00850-9
|
| 196 |
Martin Kächele, Stefan Wolff, Wolfgang Kratzer, Mark Haenle, Jörg Homann, Gerlinde Trischler, Wolfgang Koenig, Armin Imhof. Presence of Fatty Liver and the Relationship between Alcohol Consumption and Markers of Inflammation. Mediators of Inflammation 2015; 2015: 1 doi: 10.1155/2015/278785
|
| 197 |
Nurgul Toktogulova, Rustam Tukhvatshin, Elmira Mainazarova. Dynamics of Pro- and Anti-inflammatory Cytokines in Experimental Animals with Non-alcoholic Fatty Liver Disease Under Conditions of Hypobaric Hypoxia. Open Access Macedonian Journal of Medical Sciences 2021; 9(A): 822 doi: 10.3889/oamjms.2021.7016
|
| 198 |
Min Cao, Bin Cui. Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analyses. Cardiovascular Diabetology 2024; 23(1) doi: 10.1186/s12933-024-02222-1
|
| 199 |
Jonathan Gotfried, Timna Naftali, Ron Schey. Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease. Gastroenterology 2020; 159(1): 62 doi: 10.1053/j.gastro.2020.03.087
|
| 200 |
Rory P. Cunningham, Mary P. Moore, Angelique N. Moore, James C. Healy, Michael D. Roberts, R. Scott Rector, Jeffrey S. Martin. Curcumin supplementation mitigates NASH development and progression in female Wistar rats. Physiological Reports 2018; 6(14): e13789 doi: 10.14814/phy2.13789
|
| 201 |
Xing Wang, Dong-Mei Zhang, Ting-Ting Gu, Xiao-Qin Ding, Chen-Yu Fan, Qin Zhu, Yun-Wei Shi, Ye Hong, Ling-Dong Kong. Morin reduces hepatic inflammation-associated lipid accumulation in high fructose-fed rats via inhibiting sphingosine kinase 1/sphingosine 1-phosphate signaling pathway. Biochemical Pharmacology 2013; 86(12): 1791 doi: 10.1016/j.bcp.2013.10.005
|
| 202 |
Alfonso Pastor-Clerigues, Ezequiel Marti-Bonmati, Javier Milara, Patricia Almudever, Julio Cortijo, Partha Mukhopadhyay. Anti-Inflammatory and Anti-Fibrotic Profile of Fish Oil Emulsions Used in Parenteral Nutrition-Associated Liver Disease. PLoS ONE 2014; 9(12): e115404 doi: 10.1371/journal.pone.0115404
|
| 203 |
Holger Cynis, Astrid Kehlen, Monique Haegele, Torsten Hoffmann, Ulrich Heiser, Masato Fujii, Yuichiro Shibazaki, Hiroyuki Yoneyama, Stephan Schilling, Hans‐Ulrich Demuth. Inhibition of Glutaminyl Cyclases alleviates CCL2‐mediated inflammation of non‐alcoholic fatty liver disease in mice. International Journal of Experimental Pathology 2013; 94(3): 217 doi: 10.1111/iep.12020
|
| 204 |
Sheng Cao, Mengfei Liu, Tejasav S. Sehrawat, Vijay H. Shah. Regulation and functional roles of chemokines in liver diseases. Nature Reviews Gastroenterology & Hepatology 2021; 18(9): 630 doi: 10.1038/s41575-021-00444-2
|
| 205 |
Haiyan Chen, Siqi Dai, Yimin Fang, Liubo Chen, Kai Jiang, Qichun Wei, Kefeng Ding. Hepatic Steatosis Predicts Higher Incidence of Recurrence in Colorectal Cancer Liver Metastasis Patients. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.631943
|
| 206 |
Xiaolin Liu, Yongfeng Wang, Yanan Ming, Yanyan Song, Jingyi Zhang, Xiaoyu Chen, Minde Zeng, Yimin Mao, Hervé Guillou. S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis. PLOS ONE 2015; 10(5): e0127352 doi: 10.1371/journal.pone.0127352
|
| 207 |
Yufang Ding, Karin Yanagi, Fang Yang, Evelyn Callaway, Clint Cheng, Martha E Hensel, Rani Menon, Robert C Alaniz, Kyongbum Lee, Arul Jayaraman. Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice. eLife 2024; 12 doi: 10.7554/eLife.87458
|
| 208 |
Vishnubhotla Venkata Ravi Kanth, Mitnala Sasikala, Mithun Sharma, Padaki Nagaraja Rao, Duvvuru Nageshwar Reddy. Genetics of non-alcoholic fatty liver disease: From susceptibility and nutrient interactions to management. World Journal of Hepatology 2016; 8(20): 827-837 doi: 10.4254/wjh.v8.i20.827
|
| 209 |
Giuseppina Palladini, Andrea Ferrigno, Laura Giuseppina Di Pasqua, Clarissa Berardo, Vittoria Rizzo, Stefano Perlini, Mariapia Vairetti, Chen Ling. Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease. PLOS ONE 2020; 15(12): e0243179 doi: 10.1371/journal.pone.0243179
|
| 210 |
Ling Li, Minjie Xu, Chao He, Hui Wang, Qinglian Hu. Polystyrene nanoplastics potentiate the development of hepatic fibrosis in high fat diet fed mice. Environmental Toxicology 2022; 37(2): 362 doi: 10.1002/tox.23404
|
| 211 |
Sook In Chung, Hyuk Moon, Hye-Lim Ju, Kyung Joo Cho, Do Young Kim, Kwang-Hyub Han, Jung Woo Eun, Suk Woo Nam, Silvia Ribback, Frank Dombrowski, Diego F. Calvisi, Simon Weonsang Ro. Hepatic expression of Sonic Hedgehog induces liver fibrosis and promotes hepatocarcinogenesis in a transgenic mouse model. Journal of Hepatology 2016; 64(3): 618 doi: 10.1016/j.jhep.2015.10.007
|
| 212 |
Ryusei Uchio, Shinji Murosaki, Hiroshi Ichikawa. Hot water extract of turmeric (Curcuma longa) prevents non-alcoholic steatohepatitis in mice by inhibiting hepatic oxidative stress and inflammation. Journal of Nutritional Science 2018; 7 doi: 10.1017/jns.2018.27
|
| 213 |
Victor Hugo Ortenzi, Ariclecio Cunha de Oliveira, Renata Prado Vasconcelos, Marcelo Barbosa Neves, Ayla Josma Teixeira, Keciany Alves Oliveira, Andrea Claudia Freitas Ferreira, Christina Maeda Takiya, Rodrigo S. Fortunato. High-fat diet elicits sex-based differences in liver inflammatory cytokines and redox homeostasis. Applied Physiology, Nutrition, and Metabolism 2024; doi: 10.1139/apnm-2023-0457
|
| 214 |
Haeng Hur, Yeon-Hui Jeong, Sang Lee, Mi Sung. Quercitrin Ameliorates Hyperlipidemia and Hepatic Steatosis in Ovariectomized Mice. Life 2020; 10(10): 243 doi: 10.3390/life10100243
|
| 215 |
Jiro H. Situmorang, Ching-Hui Loh, Chih -Yang Huang. Proceedings of the 1st International Conference for Health Research – BRIN (ICHR 2022). 2023; : 75 doi: 10.2991/978-94-6463-112-8_8
|
| 216 |
Michael N. VanSaun, Alisha M. Mendonsa, D. Lee Gorden, Gianluigi Giannelli. Hepatocellular Proliferation Correlates with Inflammatory Cell and Cytokine Changes in a Murine Model of Nonalchoholic Fatty Liver Disease. PLoS ONE 2013; 8(9): e73054 doi: 10.1371/journal.pone.0073054
|
| 217 |
Stanislav Kotlyarov, Aleksei Bulgakov. Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease. Cells 2021; 10(11): 2978 doi: 10.3390/cells10112978
|
| 218 |
Sang Jun Yoon, Jeong Seok Yu, Byeong Hyun Min, Haripriya Gupta, Sung-Min Won, Hee Jin Park, Sang Hak Han, Byung-Yong Kim, Kyung Hwan Kim, Byoung Kook Kim, Hyun Chae Joung, Tae-Sik Park, Young Lim Ham, Do Yup Lee, Ki Tae Suk. Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1129904
|
| 219 |
Ahmed M. El-Baz, Amira M. El-Ganiny, Doaa Hellal, Hala M. Anwer, Hend A. Abd El-Aziz, Ibrahim E. Tharwat, Mohamed A. El-Adawy, Shehab El-Din M. Helal, Menna Tallah A. Mohamed, Tassnim M. Azb, Hanya M. Elshafaey, AbdulRahman A. Shalata, Sahar M. Elmeligi, Noran H. Abdelbary, Attalla F. El-kott, Fatimah A. Al-Saeed, Eman T. Salem, Mohamed M. Adel El-Sokkary, Ahmed Shata, Ahmed A. Shabaan. Valuable effects of lactobacillus and citicoline on steatohepatitis: role of Nrf2/HO-1 and gut microbiota. AMB Express 2023; 13(1) doi: 10.1186/s13568-023-01561-8
|
| 220 |
Ahmed A. Sedik, Rania Elgohary, Eman Khalifa, Wagdy K. B. Khalil, Heba I. Shafey, Mohamed B. Shalaby, Mona S. O. Gouida, Yasmin M. Tag. Lauric acid attenuates hepato-metabolic complications and molecular alterations in high-fat diet-induced nonalcoholic fatty liver disease in rats. Toxicology Mechanisms and Methods 2024; 34(4): 454 doi: 10.1080/15376516.2023.2301344
|
| 221 |
Amrit Baral, Jingxin Liu, Sandra Garcia-Davis, Bria-Necole A. Diggs, Lizelh Ayala, Anurag Aka, Yash S. Agrawal, Sarah E. Messiah, Denise C. Vidot. Prevalence of Metabolic Syndrome Among Emerging Adult Cannabis Users by Race/Ethnicity: Analysis of the 2009-2018 National Health and Nutrition Examination Surveys. American Journal of Medicine Open 2024; 11: 100069 doi: 10.1016/j.ajmo.2024.100069
|
| 222 |
Lu-Min Shih, Hsiang-Yu Tang, Ke-Shiuan Lynn, Cheng-Yu Huang, Hung-Yao Ho, Mei-Ling Cheng. Stable Isotope-Labeled Lipidomics to Unravel the Heterogeneous Development Lipotoxicity. Molecules 2018; 23(11): 2862 doi: 10.3390/molecules23112862
|
| 223 |
Z. A. Shafigullina, I. G. Danilova, S. Yu. Medvedeva, V. A. Chereshnev, M. T. Abidov. SINUSOIDAL CELLS AND CYTOKINE RESPONSE IN THE TETRACHLOROMETHANE-INDUCED HEPATOTOXICITY AND AN APPROACH TO ITS CORRECTION. Medical Immunology (Russia) 2019; 21(5): 929 doi: 10.15789/1563-0625-2019-5-929-936
|
| 224 |
Ludovico Abenavoli, Emidio Scarpellini, Samir Rouabhia, Clara Balsano, Francesco Luzza. Probiotics in non-alcoholic fatty liver disease: which and when. Annals of Hepatology 2013; 12(3): 357 doi: 10.1016/S1665-2681(19)30997-4
|
| 225 |
Howard C. Masuoka, Naga Chalasani. Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Annals of the New York Academy of Sciences 2013; 1281(1): 106 doi: 10.1111/nyas.12016
|
| 226 |
I V Kurbatova, O P Dudanova. Features of a necrotic and inflammatory process in different forms of nonalcoholic fatty liver disease. Terapevticheskii arkhiv 2017; 89(2): 52 doi: 10.17116/terarkh201789252-58
|
| 227 |
Karina Colonetti, Filippo Pinto e Vairo, Marina Siebert, Tatiéle Nalin, Soraia Poloni, Luiz Fernando Wurdig Roesch, Carolina Fischinger Moura de Souza, Franciele Cabral Pinheiro, Ida Vanessa Doederlein Schwartz. Cytokine profiling in patients with hepatic glycogen storage disease: Are there clues for unsolved aspects?. Cytokine 2023; 162: 156088 doi: 10.1016/j.cyto.2022.156088
|
| 228 |
Masaya Kozono, Hirofumi Uto, Rie Ibusuki, Shiho Arima, Kohei Oda, Hiroki Taguchi, Fumisato Sasaki, Yuichiro Nasu, Shinichi Hashimoto, Hitoshi Setoyama, Shuji Kanmura, Masatsugu Numata, Hirohito Tsubouchi, Akio Ido. Antihypertensive therapy improves insulin resistance and serum levels of interleukin-6 and −10 in spontaneously hypertensive rats with steatohepatitis. Molecular Medicine Reports 2016; 14(6): 5385 doi: 10.3892/mmr.2016.5875
|
| 229 |
Shengjie Yang, Renze Peng, Leiming Zhou. The impact of hepatic steatosis on outcomes of colorectal cancer patients with liver metastases: A systematic review and meta-analysis. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.938718
|
| 230 |
Kanishk Aggarwal, Bhupinder Singh, Abhishek Goel, Durgesh Kumar Agrawal, Sourav Bansal, Sai Gautham Kanagala, Fnu Anamika, Aachal Gupta, Rohit Jain. Complex dichotomous links of nonalcoholic fatty liver disease and inflammatory bowel disease: exploring risks, mechanisms, and management modalities. Intestinal Research 2024; doi: 10.5217/ir.2024.00001
|
| 231 |
María Rubio-Murillo, Alejandro Rodríguez-Martínez. NAFLD and NASH. 2020; : 69 doi: 10.1007/978-3-030-37173-9_5
|
| 232 |
Naoki Takatani, Yuka Kono, Fumiaki Beppu, Yuko Okamatsu-Ogura, Yumiko Yamano, Kazuo Miyashita, Masashi Hosokawa. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice. Biochemical and Biophysical Research Communications 2020; 528(2): 305 doi: 10.1016/j.bbrc.2020.05.050
|
| 233 |
Snigdha Jyoti Das, Sangit Dutta, Diptika Tiwari, Tarun Kr Basumatary, Natasha Kashyap, Manash Pratim Kalita, Sujoy Bose, Purabi Deka Bose. Prognostic value of myeloid differentiation primary response protein 88 in type II diabetes mellitus in non-obese NAFLD: A case-control study from Assam. Human Gene 2024; 39: 201246 doi: 10.1016/j.humgen.2023.201246
|
| 234 |
Kejia Liu, Xu Yang, Guihong Zhang, Zheng Xiang. Therapeutic Effect and Mechanism Prediction of Fuzi-Gancao Herb
Couple on Non-alcoholic Fatty Liver Disease (NAFLD) based on Network
Pharmacology and Molecular Docking. Combinatorial Chemistry & High Throughput Screening 2024; 27(5): 773 doi: 10.2174/1386207326666230614102412
|
| 235 |
Ramiar K. Kheder, James Hobkirk, Cordula M. Stover. In vitro Modulation of the LPS-Induced Proinflammatory Profile of Hepatocytes and Macrophages- Approaches for Intervention in Obesity?. Frontiers in Cell and Developmental Biology 2016; 4 doi: 10.3389/fcell.2016.00061
|
| 236 |
Jarkko Soronen, Hannele Yki-Järvinen, You Zhou, Sanja Sädevirta, Antti-Pekka Sarin, Marja Leivonen, Ksenia Sevastianova, Julia Perttilä, Pirkka-Pekka Laurila, Alexander Sigruener, Gerd Schmitz, Vesa M. Olkkonen. Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver disease. Physiological Reports 2016; 4(1): e12661 doi: 10.14814/phy2.12661
|
| 237 |
Samantha Teng, Lipi Chakravorty, Naomi Fleury, Shelley Gorman. Regular exposure to non-burning ultraviolet radiation reduces signs of non-alcoholic fatty liver disease in mature adult mice fed a high fat diet: results of a pilot study. BMC Research Notes 2019; 12(1) doi: 10.1186/s13104-019-4112-8
|
| 238 |
Elisa Alchera, Simona Rolla, Chiara Imarisio, Valentina Bardina, Guido Valente, Francesco Novelli, Rita Carini. Adenosine A2a receptor stimulation blocks development of nonalcoholic steatohepatitis in mice by multilevel inhibition of signals that cause immunolipotoxicity. Translational Research 2017; 182: 75 doi: 10.1016/j.trsl.2016.11.009
|
| 239 |
Liang Xu, Hironori Kitade, Yinhua Ni, Tsuguhito Ota. Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease. Biomolecules 2015; 5(3): 1563 doi: 10.3390/biom5031563
|
| 240 |
Qingpu Liu, Xuan Li, Cunyu Li, Yunfeng Zheng, Fang Wang, Hongyang Li, Guoping Peng. 1-Deoxynojirimycin Alleviates Liver Injury and Improves Hepatic Glucose Metabolism in db/db Mice. Molecules 2016; 21(3): 279 doi: 10.3390/molecules21030279
|
| 241 |
Marisa Carbonaro, Kehui Wang, Hui Huang, Davor Frleta, Aditi Patel, Alexander Pennington, Mathieu Desclaux, Sven Moller-Tank, Justin Grindley, Judith Altarejos, Jun Zhong, Greg Polites, William Poueymirou, Stephen Jaspers, Christos Kyratsous, Brian Zambrowicz, Andrew Murphy, John C. Lin, Lynn E. Macdonald, Christopher Daly, Mark Sleeman, Gavin Thurston, Zhe Li. IL-6–GP130 signaling protects human hepatocytes against lipid droplet accumulation in humanized liver models. Science Advances 2023; 9(15) doi: 10.1126/sciadv.adf4490
|
| 242 |
Chien-Chao Chiu, Yung-Hao Ching, Yen-Peng Li, Ju-Yun Liu, Yen-Te Huang, Yi-Wen Huang, Sien-Sing Yang, Wen-Ching Huang, Hsiao-Li Chuang. Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis. Nutrients 2017; 9(11): 1220 doi: 10.3390/nu9111220
|
| 243 |
Walid E. Zahran, Kholoud A. Salah El-Dien, Philip G. Kamel, Ahmed Shawky El-Sawaby. Efficacy of Tumor Necrosis Factor and Interleukin-10 Analysis in the Follow-up of Nonalcoholic Fatty Liver Disease Progression. Indian Journal of Clinical Biochemistry 2013; 28(2): 141 doi: 10.1007/s12291-012-0236-5
|
| 244 |
Maryam K. Ibrahim, Robert M. Wilechansky, Prasanna K. Challa, Xuehong Zhang, Edward Giovannucci, Meir Stampfer, Andrew T. Chan, Tracey G. Simon. The empirical dietary inflammatory pattern score and the risk of nonalcoholic fatty liver disease and cirrhosis. Hepatology Communications 2023; 7(10) doi: 10.1097/HC9.0000000000000263
|
| 245 |
Xinyue Lin, Juanhong Zhang, Yajun Chu, Qiuying Nie, Junmin Zhang. Berberine prevents NAFLD and HCC by modulating metabolic disorders. Pharmacology & Therapeutics 2024; 254: 108593 doi: 10.1016/j.pharmthera.2024.108593
|
| 246 |
Bing-Hang Li, Fang-Ping He, Xin Yang, Yuan-Wen Chen, Jian-Gao Fan. Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress. Translational Research 2017; 180: 103 doi: 10.1016/j.trsl.2016.08.006
|
| 247 |
Noha I. Hussien, Hanan I. El-kerdasy, Mohammad El-tantawy Ibrahim. Protective effect of rimonabant, a canabinoid receptor 1 antagonist, on nonalcoholic fatty liver disease in a rat model through modulation of the hepatic expression of activin A and follistatin. Canadian Journal of Physiology and Pharmacology 2017; 95(12): 1433 doi: 10.1139/cjpp-2017-0070
|
| 248 |
Thing-Fong Tzeng, Shorong-Shii Liou, Chia Ju Chang, I-Min Liu. [6]-Gingerol dampens hepatic steatosis and inflammation in experimental nonalcoholic steatohepatitis. Phytomedicine 2015; 22(4): 452 doi: 10.1016/j.phymed.2015.01.015
|
| 249 |
Cheng‐Chung Li, Chun Liu, Maobin Fu, Kang‐Quan Hu, Koichi Aizawa, Shingo Takahashi, Suganuma Hiroyuki, Junrui Cheng, Johannes von Lintig, Xiang‐Dong Wang. Tomato Powder Inhibits Hepatic Steatosis and Inflammation Potentially Through Restoring SIRT1 Activity and Adiponectin Function Independent of Carotenoid Cleavage Enzymes in Mice. Molecular Nutrition & Food Research 2018; 62(8) doi: 10.1002/mnfr.201700738
|
| 250 |
O. KUČERA, S. AL-DURY, H. LOTKOVÁ, T. ROUŠAR, D. RYCHTRMOC, Z. ČERVINKOVÁ. Steatotic Rat Hepatocytes in Primary Culture Are More Susceptible to the Acute Toxic Effect of Acetaminophen. Physiological Research 2012; : S93 doi: 10.33549/physiolres.932395
|
| 251 |
Tomasz Kostrzewski, Paloma Maraver, Larissa Ouro‐Gnao, Ana Levi, Sophie Snow, Alina Miedzik, Krista Rombouts, David Hughes. A Microphysiological System for Studying Nonalcoholic Steatohepatitis. Hepatology Communications 2020; 4(1): 77 doi: 10.1002/hep4.1450
|
| 252 |
Yue Zhang, Di Wang, Di Shen, Yang Luo, Yi-Qun Che. Identification of exosomal miRNAs associated with the anthracycline-induced liver injury in postoperative breast cancer patients by small RNA sequencing. PeerJ 2020; 8: e9021 doi: 10.7717/peerj.9021
|
| 253 |
Ju Ho Park, Dong Hun Lee, Mork Soon Park, Young Suk Jung, Jin Tae Hong. C‐C chemokine receptor type 5 deficiency exacerbates alcoholic fatty liver disease through pro‐inflammatory cytokines and chemokines‐induced hepatic inflammation. Journal of Gastroenterology and Hepatology 2017; 32(6): 1258 doi: 10.1111/jgh.13657
|
| 254 |
Charalambos Papadopoulos, Konstantinos Mimidis, Dimitris Papazoglou, George Kolios, Ioannis Tentes, Konstantinos Anagnostopoulos. Red Blood Cell-Conditioned Media from Non-Alcoholic Fatty Liver Disease Patients Contain Increased MCP1 and Induce TNF-α Release. Reports of Biochemistry and Molecular Biology 2022; 11(1): 54 doi: 10.52547/rbmb.11.1.54
|
| 255 |
Min Cheol Kim, Kyeong OK Kim. Reply to “The causal association between sarcopenia and colorectal cancer: a Mendelian randomization analysis”. The Korean Journal of Internal Medicine 2023; 38(2): 269 doi: 10.3904/kjim.2023.003
|
| 256 |
Manush Saydmohammed, Anupma Jha, Vineet Mahajan, Dillon Gavlock, Tong Ying Shun, Richard DeBiasio, Daniel Lefever, Xiang Li, Celeste Reese, Erin E Kershaw, Vijay Yechoor, Jaideep Behari, Alejandro Soto-Gutierrez, Larry Vernetti, Andrew Stern, Albert Gough, Mark T Miedel, D Lansing Taylor. Quantifying the progression of non-alcoholic fatty liver disease in human biomimetic liver microphysiology systems with fluorescent protein biosensors. Experimental Biology and Medicine 2021; 246(22): 2420 doi: 10.1177/15353702211009228
|